I agree that this site is using cookies. You can find further informations here.
X
Drandi, D.
134  results:
Search for persons X
?
1

P14.10.AMYD88L265P MUTATION IN THE DIAGNOSIS OF PRIMARY CEN..:

Bruno, F ; Bertero, L ; Ferrero, S...
Neuro-Oncology.  25 (2023)  Supplement_2 - p. ii107-ii108 , 2023
Link: https://doi.org/10.1093/..
 
?
2

P1245: CLINICAL IMPACT OF IMMUNOGLOBULIN HEAVY CHAIN REPERT..:

Alessandria, B. ; Genuardi, E. ; Civita, A. M....
HemaSphere.  6 (2022)  - p. 1130-1131 , 2022
Link: https://doi.org/10.1097/..
 
?
3

P1256: A NOVEL DROP-OFF DIGITAL PCR ASSAY FOR CXCR4 MUTATIO..:

Drandi, D. ; Ferrante, M. ; Zibellini, S....
HemaSphere.  6 (2022)  - p. 1141-1142 , 2022
Link: https://doi.org/10.1097/..
 
?
4

FIRST APPLICATION OF MINIMAL RESIDUAL DISEASE ANALYSIS IN S..:

Ferrero, S. ; Ladetto, M. ; Beldjord, K....
Hematological Oncology.  37 (2019)  S2 - p. 224-225 , 2019
Link: https://doi.org/10.1002/..
 
?
5

NOVEL MOLECULAR MARKERS FOR MINIMAL RESIDUAL DISEASE (MRD) ..:

Ferrero, S. ; Genuardi, E. ; Klous, P....
Hematological Oncology.  35 (2017)  S2 - p. 151-151 , 2017
Link: https://doi.org/10.1002/..
 
?
6

Ficoll‐hypaque separation vs whole blood lysis: Comparison ..:

Genuardi, E. ; Barbero, D. ; Dogliotti, I....
International Journal of Laboratory Hematology.  40 (2017)  2 - p. 201-208 , 2017
Link: https://doi.org/10.1111/..
 
?
7

2.37 Accelerated Activity of the Mevalonate Pathway Support..:

Coscia, M. ; Rigoni, M. ; Riganti, C....
Clinical Lymphoma Myeloma and Leukemia.  11 (2011)  - p. S182 , 2011
Link: https://doi.org/10.1016/..
 
?
8

2.28 Identification by Serological Proteome Analysis (SERPA..:

Coscia, M. ; Griggio, V. ; Capello, M....
Clinical Lymphoma Myeloma and Leukemia.  11 (2011)  - p. S176-S177 , 2011
Link: https://doi.org/10.1016/..
 
?
9

Bendamustine and rituximab as first-line treatment for symp..:

Iannitto, Emilio ; Ferrero, Simone ; Bommier, Côme...
Haematologica.  , 2024
Link: https://doi.org/10.3324/..
 
?
10

Analysis of measurable residual disease by IG/TR gene rearr..:

van der Velden, Vincent H. J. ; Dombrink, Isabel ; Alten, Julia...
Leukemia.  38 (2024)  6 - p. 1315-1322 , 2024
Link: https://doi.org/10.1038/..
 
?
11

The gray area of RQ-PCR-based measurable residual disease: ..:

Kotrova, Michaela ; Fronkova, Eva ; Svaton, Michael...
Leukemia.  38 (2024)  7 - p. 1617-1620 , 2024
Link: https://doi.org/10.1038/..
 
?
12

Editorial: The emerging role of liquid biopsies in hematolo..:

Ntanasis-Stathopoulos, Ioannis ; Drandi, Daniela
Frontiers in Oncology.  14 (2024)  - p. , 2024
Link: https://doi.org/10.3389/..
 
?
13

S221: LONG-TERM RESULTS OF THE FIL MCL0208 TRIAL COMPARING ..:

Ladetto, Marco ; Tavarozzi, Rita ; Evangelista, Andrea...
HemaSphere.  7 (2023)  S3 - p. e8994203 , 2023
Link: https://doi.org/10.1097/..
 
?
14

Minimal Residual Disease Analysis by Monitoring Immunoglobu..:

, In: Methods in Molecular Biology; Immunogenetics,
Starza, Irene Della ; Eckert, Cornelia ; Drandi, Daniela.. - p. 79-89 , 2022
Link: https://doi.org/10.1007/..
 
?
15

Punctual and kinetic MRD analysis from the Fondazione Itali..:

Ferrero, Simone ; Grimaldi, Daniele ; Genuardi, Elisa...
Blood.  140 (2022)  12 - p. 1378-1389 , 2022
Link: https://doi.org/10.1182/..
 
1-15